Bridgewater Associates’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Bridgewater Associates's ALAB Position: Q2 2026 in Review
Bridgewater Associates reduced its Astera Labs (ALAB) stake by 100% in Q2 2026, selling an estimated $199M and leaving 992 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #928.
Bridgewater Associates first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. The position peaked at $82.3M in Q1 2026. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Bridgewater Associates held 992 shares of Astera Labs worth $479K as of Q2 2026.
- Bridgewater Associates sold 749,948 Astera Labs shares in Q2 2026, an estimated $199M.
- Astera Labs made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #928 holding.
- Bridgewater Associates first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
- Bridgewater Associates's Astera Labs position peaked at $82.3M in Q1 2026.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.